Clincosm LogoSign in Get a demo

Demographic, Clinical, and Biomedical Profile of Diabetic Patients Receiving Home Healthcare in Saudi Arabia

Sponsor
Saudi Scientific Home Health Care Society (Other)
Overall Status
Completed
CT.gov ID
NCT05918653
Collaborator
(none)
252
Enrollment
2
Locations
4.5
Actual Duration (Months)
126
Patients Per Site
28
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background: Identifying characteristics of diabetic patients receiving home healthcare will help in designing services that respond to their conditions and improve their health status and quality of life. The aim of this study is to describe demographic, clinical, and biomedical characteristics of diabetic patients receiving home healthcare.

Methodology:

Descriptive cross-sectional study was conducted in King Salman Hospital in Riyadh, and Al Madinah home healthcare center in Saudi Arabia. The study Population included diabetic patients receiving home healthcare from these two health institutions. The inclusion criteria were type 1 and type 2 diabetes mellitus, all age groups, both males and females. A sample of 239 diabetic patients was selected using the stratified random sampling technique. Data were collected from the medical records of the eligible, selected study population using a structured data collection sheet. Data were analysed by statistical Package for the Social Sciences (SPSS) version 21. Categorical data were expressed as percentages with 95% confidence intervals, continuous data as mean and standard deviations.

Condition or Disease Intervention/Treatment Phase
  • Other: Home Healthcare

Detailed Description

Background:

Diabetes Mellitus (DM) is a chronic disease that affects approximately 194 million individuals, equivalent to 5.1% of the adult population globally1. In Saudi Arabia, the age-adjusted prevalence of diabetes is currently estimated to be 18.7% according to the International Diabetes Federation2. This high prevalence places the country among the top five in the Middle East and North Africa region 2 and top ten globally3.

DM can cause acute medical crises, such as diabetic ketoacidosis4, as well as long-term complications, including blindness, renal failure, and lower limb amputations1. These complications can cause significant suffering for individuals and have a considerable impact on their quality of life and overall health outcomes1,4.

To effectively prevent medical crises and long-term complications associated with diabetes, access to ongoing and timely care is crucial, and flexible follow-up schedules must also be in place to ensure comprehensive management of the disease4,5. However, the access and scheduling limitations associated with traditional clinic-based medical care might hinder the provision of such care5. Consequently, home-based care has emerged as a convenient alternative for the provision of diabetes management, particularly for elderly individuals and patients who are house-bound or bed-dependent.

Home healthcare (HHC) is a recognized model of healthcare provision that encompasses a broad range of medical and health services delivered by skilled practitioners in the patient's home6-7. DM is currently located behind congestive heart failure as the primary diagnosis for admission to HHC7,8. In Saudi Arabia, patients with diabetes mellitus are among the seventeen categories that qualify for HHC services provided by the Ministry of Health(MoH)9.

Numerous studies have evaluated the characteristics of diabetic patients in Saudi Arabia, including their glycaemic control levels3,10,11. However, there is a lack of data regarding diabetic patients who receive HHC. These patients may differ from the general diabetic population, as they may be older and experience mobility restrictions due to underlying conditions. Consequently, there is a pressing need to identify the profile of these patients to determine their current situation and to inform the development of tailored HHC services that enhance their health outcomes and overall quality of life.

  1. Objective:

2.1. General Objective To assess the Current situation of diabetic patients receiving Home

Health Care in Riyadh and Medina Regions 2.2. Specific Objectives:
  1. To identify the characteristics of diabetic patients receiving Home Health Care in
Riyadh and Medina Regions with regards to:

  • General background

  • Medical and biomedical

  • Use of outpatient services

  • Admission to hospital

  1. To describe the home healthcare provided to diabetic patients in Riyadh and Medina
Regions with regards to:

  • Types of services

  • Type of home healthcare provider

  1. Material and methods: 2.3. Study design: Descriptive cross-sectional study 2.4. Study area: 3. Study was conducted in the King Salman Hospital and Al Madinah Home Healthcare center. King Salman hospital was the first hospital to start the provision of homecare services in Riyadh region in 2005. Currently the hospital has 390 patients receiving home healthcare, around 50% of them have DM. Al Madinah Home Healthcare center was also established in 2005 and currently provides care to 581 patients, with approximately 86% of them diagnosed with DM. The scope of the services provided under the home healthcare in both centers covers diagnosis, management and follow-up of patients. Both HHC centers belong to the Saudi MoH and provide HHC services according to the regulations of the General Directorate of HHC in the MoH.

3.1. Study population: Diabetic patients receiving home healthcare by King Salman Hospital and Al Madinah Home healthcare center.

o Inclusion criteria:

  • Type1 and type 2 diabetes mellitus

  • All age groups

  • Males and females 3.2. Sampling: • Sampling technique: The sample was selected using the stratified random sampling technique. The calculated sample size was divided between the King Salman homecare centre and Al Madinah homecare centre according to the weight of diabetic patients in each centre. From each centre the diabetic patients were selected using the simple random sampling technique.

  • Sample size:

Population size(for finite population correction factor or fpc)(N): 630 Hypothesized % frequency of outcome factor in the population (p): 50%+/-5 Confidence limits as % of 100(absolute +/- %)(d): 5% Confidence level 95%

The sample was calculated using the calculator of the Open Source Statistics for Public

Health [13] assuming the following inputs:

This this yielded a sample size of 239 diabetic patients.

3.3. Data collection technique and tool: 3.3.1. Source of data:

  • Medical records of diabetic patients receiving home health care from King Salman hospital in Riyadh and Al Madinah Home healthcare center in Al Madinah.

  • Data were collected a structured, per-coded data collection sheet composed of the following sections:

  • General background information:

  • Sociodemographic characteristics (age, gender…. etc.)

  • Presence of care giver

  • Knowledge of caregiver

  • Medical information:

  • Type of diabetes

  • Medication

  • Duration of diabetes

  • Co-morbidities

  • Diabetes complications

  • Admission to hospital

  • Use of outpatient services

  • Biomedical information:

  • Blood pressure

  • Weight, height (BMI)

  • Glycated hemoglobin.

  • Fasting blood glucose (FBG),

  • Serum creatinine

  • Home healthcare

  • The types of homecare health services received

  • Type of healthcare professional providing the home healthcare

  • The frequency of the home healthcare per week/month

  • The duration of the home healthcare 3.4. Data analysis plan: Data entry and analysis were performed using Statistical Package for the Social Sciences software version 21. The data were summarized and presented as frequencies and percentages for categorical data, and means (± standard deviation) for normally distributed numerical data, and medians (range) for skewed numerical data. Using the HbA1c values, the study population was divided into two categories (HbA1c <8% and HBA1c ≥8%) according to The Saudi National Diabetes Center (SNDC) guidelines for elderly diabetic patients with comorbidities. The eGFR was calculated using age, sex, ethnicity and creatinine level, and the population was grouped based on SNDC guidelines as eGFR <60 or ≥60 mL/min/1.73m2.

3.5. Ethical considerations: The research was considered exempt from review by the Institutional Review Board (IRB) of Prince Nourah bint Abdulrahman University ( IRB log number:22-1051).

References:

  1. International Diabetes Federation. (2003). Diabetes Atlas (2nd ed.). Brussels, Belgium: International Diabetes Federation

  2. International Diabetes Federation.(2021). Diabetes in Middle-East & North Africa.

Available at:

https://www.idf.org/our-network/regions-members/middle-east-and-north-africa/diabetes-in -mena.html#:~:text=73%20million%20adults%20(20%2D79,with%20diabetes%20in%20the%20region. (accessed 15 April 2023).

  1. Alshareef SM, Aldayel AY, Alkhathlan MA, Alduaij K, Alshareef F, Al-Harthi, et al. Diabetic patients in Saudi Arabia: The evaluation of glycemic control measures based on emergency departmwent utilization and the percentage of adherence to the recommended follow-ups for microvascular complications. Saudi Med J. 2019;40(3):271-276. doi:10.15537/smj.2019.3.23968

  2. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. doi:10.2337/dc09-9032

  3. Hartman A, Creek W, Care H. In-Home Chronic Disease Management in Diabetes A Collaborative Practice Model for Home. Home Health Care Management & Practices. 2016;21(4). doi:10.1177/1084822308328323

  4. Almoajel A, Al-Salem A. The Quality of Home Healthcare Service in Riyadh/Saudi Arabia. AjscLeena-LunaCoJp. 2016;5(2):72-81. http://www.ajsc.leena-luna.co.jp/AJSCPDFs/Vol.5(2)/AJSC2016(5.2-08).pdf

  5. Sertbas M. Current situation analysis of diabetic home care patients. North Clin Istanbul. 2019;7(2):140-145. doi:10.14744/nci.2019.59751

  6. O'Reilly CA. Managing the care of patients with diabetes in the home care setting. Diabetes Spectr. 2005;18(3):162-166. doi:10.2337/diaspect.18.3.162

  7. Depuityship of theraputic care. home healthcare manual. Ministry of Health. Riyadh Saudi Arabia.

  8. Alramadan MJ, Magliano DJ, Almigbal TH, et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia - an urgent need for a review of management plan. BMC Endocr Disord. 2018:1-12.

  9. Elhadd TA, Al-amoudi AA. Epidemiology, Clinical and Complications Profile of Diabetes in Saudi Arabia: A Review. Ann Saudi Med. 2007;27(August):241-250.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
252 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Demographic, Clinical, and Biomedical Profile of Diabetic Patients Receiving Home Healthcare in Saudi Arabia
Actual Study Start Date :
Dec 15, 2022
Actual Primary Completion Date :
Feb 15, 2023
Actual Study Completion Date :
May 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Biomedical profile of diabetic patients [three months]

    proportion of diabetic patients with Glycated haemoglobin less than 8%

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Type1 and type 2 diabetes mellitus

  • All age groups

  • Males and females

  • Receiving home healthcare

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Al Madinah Home Healthcare center Al Madinah Saudi Arabia 42210
2 King Salman Hospital Riyadh Saudi Arabia 12769

Sponsors and Collaborators

  • Saudi Scientific Home Health Care Society

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lamya Mohammed Alzubaidi, Member, Saudi Scientific Home Health Care Society
ClinicalTrials.gov Identifier:
NCT05918653
Other Study ID Numbers:
  • 01
First Posted:
Jun 26, 2023
Last Update Posted:
Jun 26, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 26, 2023